Structure-Based Drug Design, Cambridge, MA, USA
Event Apr 28
The past year has seen a steady and exciting growth of novel inhibitors identified through computational analysis of target structure. A combination of more structures, advances in homology modeling, better docking and scoring tools, fragment-based methods, and advances in virtual screening has been fundamental in this progress. De novo design of small molecules is clearly becoming a valuable and integral part of the drug discovery, and the results are emerging. Structure Based Drug Design hears case studies of successful generation of leads from structure-based design and medicinal chemistry efforts and learn how to apply these approaches to make your own discovery and development more efficient and productive.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018